ContributorsPublishersAdvertisers

Johnson & Johnson, Amgen win FDA approval for drug combo targeting multiple myeloma

Seeking Alpha
Seeking Alpha
 2021-12-01
Cover picture for the article

On Tuesday, the FDA approved a new therapeutic combination consisting of two treatments from Janssen Biotech of Johnson & Johnson (NYSE:JNJ) and Amgen (NASDAQ:AMGN) for adults with relapsed or refractory...

seekingalpha.com

Comments / 0

Comments / 0